Form 4: Aquestive Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Sherry Korczynski, Chief Commercial Officer of Aquestive Therapeutics, Inc., reported a transaction in 2,714 shares of common stock on August 14, 2026.
Summary
- Tax/exercise-price withholding: disposed of 2,714 Common Stock at $4.25 ($11,534) on August 14, 2026; holds 235,689 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sherry Korczynski — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Tax/exercise-price withholding | Common Stock | 2,714 | $4 | $11.5K | 235,689 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Tax/exercise-price withholding (2,714 shares) |
Keywords
insider transaction, Form 4, AQST, Aquestive Therapeutics, Inc., neutral, Sherry Korczynski
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.